Laurus Labs has agreed to acquire 100% shares of Phekolong Pharmaceuticals, a wholly owned subsidiary company of Pharmacare t/a Aspen Pharmacare, South Africa, subject to completion of conditions precedent, by way of cash consideration of South African Rand (ZAR) 75,000.
This transaction will provide the company access to the South African public antiretroviral (ARV) sector, which manages the world's largest public ARV programme. While Aspen will continue to manufacture the finished dose form ARV's for the South African public sector, the supply to this sector will be through Laurus' newly acquired South African subsidiary.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1783.90 |
Dr. Reddys Lab | 1199.30 |
Cipla | 1523.30 |
Lupin | 2115.70 |
Zydus Lifesciences | 918.35 |
View more.. |